Arnold S. Monto to Keynote at Influenza Conference on July 9-11, 2014, in Boston, MA
Boston, MA, June 19, 2014 --(PR.com
)-- Dr. Arnold S. Monto, Thomas Francis Jr. Collegiate Professor, University of Michigan School of Public Health’s Department of Epidemiology to give a keynote presentation on, “Controversies in Influenza Control: Are They Real?” at the 3rd Annual Influenza Research and Development Conference on July 9-11, 2014, in Boston, MA, by GTCbio.
Dr. Monto’s major focus has been the epidemiology, prevention and treatment of acute infections in the individual and the community. Respiratory infections, in particular influenza, have been a major interest. He has worked on these issues in tropical as well as temperate regions. He led the studies of respiratory infection in Tecumseh, MI, a landmark study of infection in the community, and is now updating these observations in Michigan households with children. Dr. Monto is involved in assessing the efficacy of various types of influenza vaccine in prophylaxis and antivirals in prophylaxis and therapy of influenza. He now heads an observational study of effectiveness of influenza vaccines in various settings. His recent activities have included evaluation of face masks and hand hygiene in the control of influenza transmission and determination of efficacy of the traditional inactivated and live attenuated influenza vaccines. He has been a member of the National Allergy and Infectious Disease Advisory Council of the US National Institutes of Health. He is a past president of the American Epidemiological Society, the 2009 recipient of the Alexander Fleming Award of the Infectious Diseases Society of America for lifetime achievement and the 2012 recipient of the Charles Merieux award of the National Foundation for Infectious Diseases. He was a member of the Emergency Committee making recommendations to the World Health Organization during the last influenza pandemic.
GTCbio’s 3rd Annual Influenza Research and Development Conference will bring together experts from industry, government and academia to discuss the issues facing the influenza field. Topics will range from basic science of the influenza virus itself to pandemic preparedness to vaccination and clinical development. Attend this conference to learn, discuss and network with fellow scientists and researchers involved in various sectors of the influenza filed in an intimate setting.
This conference is also part of the Infectious Diseases World Summit 2014, which consists of this conference and two other conferences:
1) 12th Vaccines Research & Development: All Things Considered Conference
2) 11th Anti-infectives Partnering and Deal-Making Conference
For more information, please visit www.gtcbio.com